secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEON Biopharma, Inc. (AEON)
CIK:        0001837607
Form:       8-K
Filed at:   2026-07-15T20:01:21+00:00
Accession:  0001837607-26-000052
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AEON Biopharma prices upsized $13.75M public offering with milestone warrants for potential $29.6M additional proceeds
--------------------------------------------------------------------------------

- Offering of 42,688,606 shares (or pre-funded warrants) plus two-year and five-year milestone warrants at combined price of $0.3221 per share.
- Gross proceeds of ~$13.75M; up to $29.6M more if all milestone warrants exercised for cash.
- Net proceeds of ~$12.2M to be used for working capital and ABP-450 biosimilar testing.
- Underwriters granted 30-day over-allotment option for up to 6,403,290 additional shares/warrants.
- Offering closed July 15, 2026; lock-up agreements for 90 days from closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000052/0001837607-26-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1837607/000183760726000052/aeon-20260713x8k.htm
  HTML page:      https://secwatch.observer/filing/0001837607-26-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer